TherapeuticsMD, Inc. (TXMD) Financial Statements (2026 and earlier)

Company Profile

Business Address 951 YAMATO ROAD, SUITE 220
BOCA RATON, FL 33431
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,7335,0594,32738,06765,12280,486
Cash and cash equivalent7,7335,0594,32738,06765,12280,486
Restricted cash and investments    11,250  
Receivables     36,17632,382
Inventory, net of allowances, customer advances and progress billings     7,6227,993
Inventory     7,6227,993
Prepaid expense4311,3041,7013,7008,2446,208
Disposal group, including discontinued operation   344   
Other undisclosed current assets6,2815,8965,4242,3342,3041,335
Total current assets:14,44512,25911,79655,351119,468128,404
Noncurrent Assets
Operating lease, right-of-use asset5,2936,1026,8737,5808,234 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization    781,1991,942
Intangible asset, including goodwill, after accumulated amortization3,7614,3216,0986,94340,318 
Intangible asset, excluding goodwill, after accumulated amortization3,7614,3216,0986,94340,318 
Other noncurrent assets4441305825325351,263
Other undisclosed noncurrent assets13,71316,01018,48420,253  
Total noncurrent assets:23,21126,56331,51335,10750,00453,206
TOTAL ASSETS:37,65638,82243,30990,458169,472181,610
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1437521,6872,16227,60621,068
Accounts payable377258272,16220,31821,068
Accrued liabilities7664941,660 7,288 
Debt     188,269 
Disposal group, including discontinued operation2,6672,7813,69425,831  
Other liabilities    18,846 38,170
Other undisclosed current liabilities9751,6331,473 37,016 
Total current liabilities:4,7855,1666,85446,839252,89159,238
Noncurrent Liabilities
Long-term debt and lease obligation     8,063246,373
Long-term debt, excluding current maturities      237,698
Liabilities, other than long-term debt5,9956,2867,1688,4762,139 
Disposal group, including discontinued operation, liabilities   6,532   
Other liabilities8737446361,1072,139 
Operating lease, liability5,1225,542 7,3698,0638,675
Other undisclosed noncurrent liabilities      (8,675)
Total noncurrent liabilities:5,9956,2867,1688,47610,202246,373
Total liabilities:10,78011,45214,02255,315263,093305,611
Equity
Equity, attributable to parent26,87627,37029,28735,143(93,621)(124,002)
Common stock1111119430300
Additional paid in capital979,256979,181978,917974,497957,309754,644
Accumulated deficit(952,391)(951,822)(949,641)(939,363)(1,051,360)(878,945)
Total equity:26,87627,37029,28735,143(93,621)(124,002)
TOTAL LIABILITIES AND EQUITY:37,65638,82243,30990,458169,472181,610

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues3,0221,7611,30269,96386,95164,872
Sublease income1,847  400  
Cost of revenue
(Cost of Product and Service Sold)		    (1,397)(18,838)(15,975)
Gross profit:3,0221,7611,30268,56668,11348,897
Operating expenses(7,412)(6,521)(9,825)(67,375)(207,883)(204,438)
Operating income (loss):(4,390)(4,760)(8,523)1,191(139,770)(155,541)
Nonoperating income (expense)3,7372,417781(117)(32,645)(27,983)
Investment income, nonoperating1422,4441,800   
Other nonoperating income (expense)    (117)272598
Interest and debt expense(8)(10)(300)(36,065)(32,917)(275)
Income (loss) from continuing operations before equity method investments, income taxes:(661)(2,353)(8,042)(34,991)(205,332)(183,800)
Other undisclosed income from continuing operations before income taxes81030036,06532,917275
Income (loss) from continuing operations before income taxes:(653)(2,343)(7,742)1,074(172,415)(183,524)
Income tax benefit  3143   
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:(653)(2,312)(7,699)1,074(172,415)(183,524)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(172,415)(183,524)
Income (loss) from discontinued operations84131(2,579)   
Net income (loss):(569)(2,181)(10,278)1,074(172,415)(183,524)
Other undisclosed net income attributable to parent    110,923  
Net income (loss) available to common stockholders, diluted:(569)(2,181)(10,278)111,997(172,415)(183,524)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(569)(2,181)(10,278)1,074(172,415)(183,524)
Comprehensive income (loss):(569)(2,181)(10,278)1,074(172,415)(183,524)
Other undisclosed comprehensive income, net of tax, attributable to parent    110,923  
Comprehensive income (loss), net of tax, attributable to parent:(569)(2,181)(10,278)111,997(172,415)(183,524)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: